Literature DB >> 168957

Survival with mammary cancer related to the interaction of germinal center hyperplasia and sinus histiocytosis in axillary and internal mammary lymph nodes.

R L Hunter, D J Ferguson, L W Coppleson.   

Abstract

In a review of the histologic sections of axillary and internal mammary lymph nodes removed during surgery for invasive ductal carcinoma of the breast, we found that 16 of 17 patients in whom sinus histiocytosis was the dominant lymphoid proliferative reaction are alive with no evidence of cancer 5 or more years after operation. In contrast, 5 of 6 patients in whom germinal center hyperplasia was the only significant reaction found died of cancer in less than 5 years. Patients with both sinus histiocytosis and germinal center hyperplasia in significant amounts had survival that was intermediate; 17 of 25 of these patients are currently alive and apparently free of cancer. In addition, 5 of 6 patients in whom no evidence was found of any lymphoid proliferative reaction and 3 of 3 patients with diffuse cortical hyperplasia in their axillary lymph nodes died of cancer in less than 5 years. Germinal center hyperplasia was associated with nodal metastases anatomically in individual lymph nodes and statistically in the series of cases. The internal mammary lymph nodes of most cases showed less proliferative reaction to tumor than the axillary lymph nodes. The pattern of proliferative reactions in lymph nodes and its correlation with survival after surgery suggest that different immune reactions may either suppress or enhance the growth of carcinoma of the breast.

Entities:  

Mesh:

Year:  1975        PMID: 168957     DOI: 10.1002/1097-0142(197508)36:2<528::aid-cncr2820360232>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Lymphatic invasion and metastasis.

Authors:  C van de Velde; I Carr
Journal:  Experientia       Date:  1977-07-15

Review 2.  The role of histopathology in diagnosis and prognosis of oral squamous cell carcinoma.

Authors:  N W Johnson
Journal:  Proc R Soc Med       Date:  1976-10

3.  Immunomorphological study of 216 cases of reactive hyperplasia in lymph nodes.

Authors:  H M Wu; S Z Yang
Journal:  Acta Acad Med Wuhan       Date:  1985

4.  Immunological characterization of mononuclear cells and morphological findings in patients with mammary carcinoma.

Authors:  W Heidenreich; K Jagla; J Schüssler; P Börner; F Dehnhard; J Deinhardt; J Kalden; H H Peter; H Deicher
Journal:  J Cancer Res Clin Oncol       Date:  1979-09       Impact factor: 4.553

5.  Identification of novel tumor antigens with patient-derived immune-selected antibodies.

Authors:  Daniel Rodriguez-Pinto; Jason Sparkowski; Martin P Keough; Kathryn N Phoenix; Frank Vumbaca; David K Han; Eckart D Gundelfinger; Philip Beesley; Kevin P Claffey
Journal:  Cancer Immunol Immunother       Date:  2008-06-21       Impact factor: 6.968

6.  Reactive hyperplasia of paracortex and germinal centers of the regional lymph nodes in gastric carcinoma cases as a favorable prognostic indicator.

Authors:  Y Kodama; K Seojima; K Inokuchi
Journal:  Jpn J Surg       Date:  1976-03

7.  Pathology of primary tumors and axillary lymph nodes in British and Japanese women with breast cancer.

Authors:  G H Friedell; E A Soto; S Kumaoka; T Hirota; J L Hayward; R D Bulbrook
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

8.  The influence of lymph node metastasis and ulceration of primary melanoma on germinal centers within draining lymph nodes: a histomorphometric study.

Authors:  F Weidner; S Schroll; A Schönberger
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

9.  A quantitative study of mast cells in Hodgkin's disease.

Authors:  J Crocker; P J Smith
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

10.  Pregnancy-associated plasma protein A. A clinically significant predictor of early recurrence in stage I breast carcinoma is independent of estrogen receptor status.

Authors:  F P Kuhajda; J C Eggleston
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.